Stan Bukofzer, SVP, Chf Scitfc & Technology Officer at Assertio Therapeutics, Inc (ASRT), bought 5,000 shares at $4.13 ($21K) on 2019-03-14, disclosed to the SEC on 2019-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |